Potential Impact of Takeda’s Dengue Vaccine Candidate Reinforced by Long-Term Safety and Efficacy Results
− Takeda’s Dengue Vaccine Candidate (TAK-003) Prevented 83.6% of Hospitalizations and 62.0% of Dengue Illness Overall, ...
Read more
Tag: Takeda
US FDA grants Priority Review to Mobocertinib of Takeda
Takeda Pharmaceutical Company Limited announced that the U.S. Food and Drug Administration (FDA) has granted priority ...
Read more
Takeda Completes Sale of Select OTC and Non-Core Assets to Orifarm
Takeda Pharmaceutical Company Limited today announced the completion of its previously-announced sale of a portfolio of ...
Read more